Stay updated on Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.

Latest updates to the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page, reflecting a site revision update. No study-specific data or outcomes appear to be changed.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded the keywords 'Schizophrenia' and the related topic 'MedlinePlus Genetics' to the study record to enhance indexing and context.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedSchizophrenia and MedlinePlus Genetics topics were removed from the page's taxonomy/navigation. This metadata change does not modify the study details.SummaryDifference0.1%

- Check33 days agoChange DetectedWebsite revision updated from v3.4.1 to v3.4.2. No visible changes to the study details or documents.SummaryDifference0.0%

- Check40 days agoChange DetectedNew MeSH topics on the page include 'Schizophrenia' and related topics ('MedlinePlus Genetics'), and the revision version changed from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.